Stock fact sheet · data as of
Sangrix Inc. (SGRX): fair value, margin of safety and Wheel Score
Consumer Defensive · Agricultural Farm Products · Singapore · Speculative / Distressed
Is SGRX undervalued?
SGRX has a margin of safety of 98%: the stock closed at 0.6077 on 16 Oct 2026 against a GLS average fair value of 33.72. 1 of the 1 valuation models that produced a number sit above the price. Our screens treat a discount this large as a strong starting point for a cash-secured put, not as a verdict - the fair value is a model output, and a wide gap can mean the models are missing something the market knows.
Only 1 of the nine models produced a value (DCF); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.
The nightly engine files SGRX under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.
Nine valuation models for SGRX
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 33.72 | +5449% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | - | - | The most a defensive investor pays for the earnings and book value per share; no value tonight |
| Graham Growth | - | - | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight |
| Lynch | - | - | EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight |
| GLS Growth | - | - | EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight |
| 10 Cap | - | - | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight |
| Payback Time | - | - | Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | - | - | Earnings power value: current EPS capitalised at 9% with no growth; no value tonight |
| Zombie (liquidation) | 3.96 | +551% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is weak: SGRX passes 3 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 1.2 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.
Returns on capital are thin or negative - ROIC -112.5%, ROE -112.5%, ROA -124.1% - with debt at 0.00 times equity and negative free cash flow.
Sangrix Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.
Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 3 / 9 | ROIC | -112.5% |
|---|---|---|---|
| GLS Moat | 1.2 / 10 | ROE | -112.5% |
| Debt / equity | 0.00 | ROA | -124.1% |
| Free-cash-flow yield | 0.0% | Payout ratio | 0% |
| Institutions | 5 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 39: No options
SGRX has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.
Volume runs at 387k shares a day on a market cap of $486K, with a beta of 2.01 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 7 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 25 / 25 | 98% margin of safety | |
| Health | 7 / 20 | Piotroski 3/9 | |
| Moat | 2 / 15 | moat 1.2/10 | |
| Premium | 0 / 20 | no option data | |
| Stability | 7 / 20 | 387k shares/day, $0M cap, beta 2.01 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for SGRX in the nightly calendar.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Agricultural Farm Products
The 12 companies below are the closest to Sangrix Inc. by market cap within the Agricultural Farm Products industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| EDBL Edible Garden AG Incorporated | 0.9125 | - | - | 20No options | $111K |
| AGRZ Agroz Inc. Ordinary Shares | 2.96 | 40.28 | +93% | 39No options | $3M |
| MGNC Mag Magna Corp. | 0.5500 | - | - | 20No options | $3M |
| AQB AquaBounty Technologies, Inc. | 1.10 | - | - | 24No options | $6M |
| SISI Shineco, Inc. | 0.1050 | - | - | 31No options | $33K |
| SDOT Sadot Group Inc. | 8.45 | - | - | 24No options | $9M |
| ESGH ESG Inc. | 0.8098 | 2.11 | +62% | 39No options | $13M |
| LOCL Local Bounti Corporation | 0.9732 | - | - | 21No options | $23M |
| STNT Stevia Nutra Corp. | 6.37 | 0.3488 | -1725% | 8No options | $162M |
| LMNR Limoneira Company | 11.82 | 2.21 | -436% | 23Weak | $214M |
| ALCO Alico, Inc. | 37.98 | 4.13 | -821% | 21No options | $282M |
| CHSCN CHS Inc. | 23.55 | 27.59 | +15% | 39No options | $305M |
⚖ Compare SGRX with 7 of them All Consumer Defensive stocks →
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about SGRX
Is SGRX undervalued right now?
By the GLS models, yes: at 0.6077 the stock is 98% below the average fair value of 33.72 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of SGRX and what does it mean?
SGRX has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".
What is the GLS fair value for SGRX?
33.72 per share as of 16 Oct 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Sangrix Inc. report earnings next?
No upcoming earnings date is recorded for SGRX in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.
Does SGRX have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on SGRX, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.